| Clinical cohort number | Controls number | Source | Circulating miRNAs detected | Association/correlation | Reference |
| 33 AMI | 30 | Plasma | 1, 133a, 208a, 499↑ | miR-208a shows highest sensitivity and specificity comparable with cTnI | [47] |
| 33 STEMI | 17 | Plasma | 1, 133a, 133b, 499-5p↑ | Time course of upregulated miRNA associated with cTnI | [48] |
| 31 AMI | 20 | Serum | 1↑ | Association with CK-MB levels | [50] |
| 93 AMI | 66 | Plasma | 1↑ | Association with QRS duration | [51] |
| 9 AMI, 5 UAP | 10 | Plasma | 499↑ in AMI (within 48 h) | Correlation with CK-MB | [62] |
| 32 AMI, 36 non-AMI | — | Plasma | 208b, 133a, 499↑ | miR-208b and miR-499 correlation with cTnT | [61] |
| 20 AMI | 20 | Whole blood | 30c, 145↑ 663b, 1291↓ | miR-30c and miR-145 correlated with hs-cTnT | [65] |
| 29 ACS, 42 without ACS | — | Serum | 1, 133a↑ | Correlation with cTnT | [57] |
| 444 ACS | — | Plasma | 1, 133a/b, 208b↑ | miR-133a and miR-208b associated with risk of death | [66] |
| 397 STEMI, 113 NSTEMI | 87 | Plasma | 208b, 499↑ | miR-499 showed diagnostic accuracy comparable with hs-cTnT | [67] |
| 92 AMI, 81 CHF | 66 | Plasma | 1, 21, 133a, 423-5p, 499-5p↑ | miR-499 showed diagnostic accuracy comparable with hs-cTnT | [68] |
| 33 acute HF | 34 | Plasma | 499↑ | — | [61] |
| 30 HF, 20 dyspnoea | 39 | Plasma | 423-5p↑ | miR-423-5p is a predictor of heart failure | [74] |
| 33 CHF | 17 | Plasma | miR-126↓ | miR-126 negatively correlated with age, BNP, and NYHA class | [71] |
| 31 stable CAD | 14 | Plasma | 17, 92a, 126, 145, 155↓ | Association with age, gender, and diabetes | [63] |
| 13 UAP with CAD | 13 | Plasma | 106b/25, 17/92a, 21/590-5p, 126, 451↑ | Association with disease | [76] |
|
|